FDA Inspection
LaNaturaLaNatura – FDA Inspection, May 25, 2017
Record Details
This FDA Inspection record concerns LaNatura, with an inspection on May 25, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fcc1714d-cae0-4307-96a9-2f451870087a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012064
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.137(d)Expiration date location on labeling
- 21 CFR 211.101(d)Component addition checked by 2nd person
- 21 CFR 211.84(e)Rejecting When Specifications Not Met
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(a)(1)Sample size - test intervals
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LaNatura
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LaNatura
- FDA Inspection 714474 - 2011-03-15
- FDA Inspection 662692 - 2010-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.